New Scientific Discovery Explains Chronic Constipation: The Role of Gut Bacteria

Two gut bacteria may erode the colon’s protective mucus — redefining how we understand chronic constipation.

Chronic constipation affects millions worldwide, yet for many patients, traditional treatments fail to provide lasting relief. A groundbreaking study from Nagoya University in Japan has uncovered a surprising microbial mechanism that may explain why. Instead of slow bowel movement alone, researchers found that specific gut bacteria may erode the colon’s protective mucus layer — leading to dry, hardened stool and persistent constipation.

This discovery opens the door to a new understanding of digestive health and offers hope for more targeted, effective treatments in the future.

Understanding Chronic Constipation: More Than Slow Digestion

Chronic constipation is typically defined as having fewer than three bowel movements per week, accompanied by symptoms such as:

• Hard or lumpy stools
• Straining during bowel movements
• A feeling of incomplete evacuation
• Abdominal discomfort or bloating

For decades, medical treatment has focused primarily on stimulating bowel motility — using laxatives, fiber supplements, and medications that increase intestinal contractions. While these approaches help some patients, millions suffer from chronic idiopathic constipation, meaning the cause remains unknown.

The new research suggests the root problem may not always be movement speed — but moisture balance within the colon.

The Protective Mucus Layer: The Colon’s Natural Lubrication System

The colon is lined with a gel-like protective barrier made primarily of a substance called colonic mucin. This mucus layer serves several essential functions:

• Keeps stool hydrated and soft
• Lubricates waste to ease passage
• Protects the intestinal wall from harmful bacteria
• Maintains a healthy gut environment

When this mucus layer becomes damaged or depleted, stool loses moisture, becomes dry and hard, and becomes difficult to expel — even if intestinal movement remains relatively normal.

The Bacterial Collaboration Behind “Bacterial Constipation”

Researchers identified two common gut bacteria that appear to work together in breaking down this protective mucus layer:

• Akkermansia muciniphila
• Bacteroides thetaiotaomicron

Both species normally live in the human gut and play roles in digestion. However, the study found that under certain conditions, they cooperate in a way that damages mucin.

Step 1: Removing Protective Sulfate Groups

Bacteroides thetaiotaomicron produces an enzyme called sulfatase, which removes protective sulfate groups from mucin molecules. These sulfate groups normally shield mucin from rapid degradation.

Step 2: Mucus Breakdown and Consumption

Once the protective groups are removed, Akkermansia muciniphila breaks down and consumes the exposed mucin as a food source.

The result? Reduced mucus levels, decreased colon hydration, and harder stool formation.

Researchers have termed this mechanism “bacterial constipation.”

Why Traditional Treatments Often Fail

Standard constipation treatments typically focus on:

• Stimulating bowel contractions
• Increasing fiber intake
• Drawing water into the colon

However, if the underlying issue is the erosion of the mucus layer, simply increasing movement may not solve the problem. Without adequate mucin, stool lacks natural lubrication and hydration.

This explains why some individuals remain constipated despite aggressive laxative therapy.

The Surprising Link to Parkinson’s Disease

One of the most intriguing aspects of the study is its connection to Parkinson’s disease.

Chronic constipation is a well-known early symptom of Parkinson’s — often appearing years or even decades before neurological symptoms develop.

The researchers found that patients with Parkinson’s disease had higher levels of these mucus-degrading bacteria. Previously, constipation in Parkinson’s patients was attributed primarily to nerve damage affecting gut motility. This new evidence suggests that microbial imbalance may play a significant early role.

This insight could have profound implications for early detection and prevention strategies.

The Animal Study: Proof of Concept

To confirm the mechanism, researchers genetically modified Bacteroides bacteria so they could no longer produce the sulfatase enzyme.

When introduced into germ-free mice alongside Akkermansia:

• The mucus layer remained intact
• The animals did not develop constipation
• Colon hydration levels stayed normal

This experiment strongly supports the idea that the sulfatase enzyme is central to the development of bacterial constipation.

Future Treatment Possibilities

This discovery opens several potential therapeutic pathways:

1. Sulfatase Inhibitors

Drugs that block the sulfatase enzyme could prevent mucus degradation at its source.

2. Microbiome Modulation

Targeted probiotics or microbiome therapies could rebalance gut bacteria populations.

3. Personalized Medicine

Testing stool samples for specific bacterial patterns may help identify patients who would benefit from microbiome-based treatment rather than traditional laxatives.

The Role of the Gut Microbiome in Overall Health

This study reinforces the growing understanding that the gut microbiome plays a central role in human health. Beyond digestion, gut bacteria influence:

• Immune system regulation
• Metabolic health
• Inflammation levels
• Brain-gut communication

The connection between gut bacteria and neurological diseases like Parkinson’s further highlights the importance of maintaining microbial balance.

Practical Takeaways for Digestive Health

While targeted therapies are still under development, individuals can support gut health by:

• Eating a diverse, fiber-rich diet
• Consuming fermented foods
• Staying hydrated
• Avoiding unnecessary antibiotic use
• Managing stress levels

However, persistent constipation should always be evaluated by a healthcare professional.

Redefining Chronic Constipation

The discovery of “bacterial constipation” represents a significant shift in how we understand chronic digestive disorders. Instead of viewing constipation solely as a motility issue, this research highlights the critical importance of the colon’s mucus layer and microbial balance.

While more human studies are needed, this breakthrough could pave the way for innovative treatments that address the root cause rather than just the symptoms.

As science continues to unravel the complexities of the gut microbiome, one thing becomes increasingly clear: digestive health is deeply interconnected with overall well-being.